The dosing schedule begins with an initiation dose of 2.5 mg weekly for 4 weeks (not intended for glycaemic control), which is then gradually increased every four weeks to minimise gastrointestinal side effects
[1] However, the clinical significance of these modest elevations remains uncertain, as they occurred in the context of substantial weight loss and improvements in other cardiovascular risk factors, including blood pressure, lipid profiles, and glycemic control in patients with type 2 diabetes
Start your intake What Does Current Research Say About GLP-1 and Pregnancy
Storage and Handling of DSIP 5mg Store sealed at recommended laboratory freezer temperatures
In a clinical trial for weight reduction in pediatric patients aged 12 years and older with normal baseline heart rate, more patients treated with Wegovy compared to placebo had maximum changes in heart rate of 20 bpm or more (54% versus 39%)
Tesamorelin / CJC-1295 / Ipamorelin What Is Tesamorelin / CJC-1295 / Ipamorelin
